Omega Healthcare Investors (OHI) EBIT Margin (2009 - 2026)

Omega Healthcare Investors has disclosed EBIT Margin across 16 years of filings, most recently posting 3149.66% for Q1 2026.

• EBIT Margin for Q1 2026 came in at 3149.66%, up 308937.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 95.9% (up 3325.0% YoY), and the FY2025 annual result was 70.54%, up 943.0% from the prior year.
• EBIT Margin came in at 3149.66% for Q1 2026 at Omega Healthcare Investors, up from 69.87% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 3149.66% in Q1 2026 to a low of 42.74% in Q1 2023.
• The 5-year median for EBIT Margin is 64.37% (2023), against an average of 246.12%.
• Across the five-year window, EBIT Margin sank 230052 bps in 2022 and soared 308937 bps in 2026, its largest moves.
• Omega Healthcare Investors' EBIT Margin stood at 73.51% in 2022, then sank by 31 bps to 50.67% in 2023, then rose by 23 bps to 62.25% in 2024, then rose by 12 bps to 69.87% in 2025, then surged by 4408 bps to 3149.66% in 2026.
• The last three EBIT Margin figures came in at 3149.66% (Q1 2026), 69.87% (Q4 2025), and 80.06% (Q3 2025), per Business Quant data.